Decentralised clinical trials

Clinical trial
#Cannabinoid #Clinical trial design #Clinical trials #Contract Research Organisations (CROs) #Decentralised clinical trials #Medicinal cannabis #Plant-based

New podcast: How to utilise clinical trials in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers three articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Medicinal cannabis: Why more clinical… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial design #Clinical trials #Data security #Decentralised clinical trials

Decentralised identities: Blockchain based informed consent

Industry experts explain how blockchain can fundamentally enhance clinical trials. Obtaining consent from patients or healthy volunteers is a fundamental requirement for enrolling participants on to clinical trials. Methods for obtaining consent use paper-based Informed Consent Forms (ICFs) must be signed on site by the participant in the presence of… Read More

#Exclusive Content

Patient advocacy group
#Clinical trial design #Clinical trials #Decentralised clinical trials #Drug development #Patient centricity #Rare disease

Recruiting and retaining patients for successful drug development

Craig Stevens, Senior Patient Engagement Specialist, and Amanda Henkel, VP, Strategy from MEDiSTRAVA (an Inizio Company), delve into the challenges and opportunities that surround clinical trial design for rare diseases. The drug development process requires collaboration at all stages, and is particularly important in the rare disease setting, where in… Read More

#Exclusive Content

Dermatology patient
#Clinical trial design #Clinical trials #Decentralised clinical trials #ICON #LEO Pharma

LEO partners with ICON to offer patient-centric dermatology trials

LEO Pharma and ICON have formed a strategic partnership that will enable LEO to offer clinical trials within medical dermatology that are patient-centric and cost effective. The partnership will operate under the acronym of PACE, reflecting the requirement to move quickly to address today’s clinical development challenges. Read More

#News

#Clinical trial design #Clinical trials #Contract Research Organisations (CROs) #Decentralised clinical trials

Choosing the right site solution for clinical trials

Listen to this article on the DDW podcast: Independent Medical Writer Leonie Onslow explores the challenges of traditional clinical trial models and how to improve recruitment and retention. Covid-19 and the subsequent strain on health systems and research capabilities has created the opportunity to change the traditional clinical trial model of… Read More

#Exclusive Content

#Clinical trial design #Clinical trials #Decentralised clinical trials

What are the opportunities for decentralised clinical trials?

Listen to this article on the DDW podcast: Tom Brazier, Director, Decentralised Clinical Solutions, mdgroup and Stephanie Larimer, Q² Solutions discuss the opportunities for decentralised clinical trials and how common pitfalls can be avoided through communications and streamlined working. Hybrid and decentralised clinical trials (DCTs) are fast becoming the norm, but… Read More

#Exclusive Content

#Clinical trials #Decentralised clinical trials #Digitalisation

Cambridge Cognition set to become key player in virtual clinical trials 

Cambridge Cognition has entered into an agreement to acquire eClinicalHealth Ltd (eCH), a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.   Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly… Read More

#News

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Decentralised clinical trials #Patient centricity

Covid-related changes to clinical trials here to stay

The Covid-19 pandemic has led to improvements in clinical trial processes and a more technology-driven approach, a new report from Medidata has revealed. The report ‘European Industry Research Report: The Future of Clinical Trials’ includes insights from 400 clinical trial executives across the United Kingdom, France, Germany and Switzerland. The… Read More

#Covid-19 #News

#Clinical trials #Decentralised clinical trials #Queen’s Award

Medical Research Network wins Queen’s Award for clinical trials 

Clinical trial support organisation Medical Research Network (MRN) has won a Queen’s Award for Enterprise for International Trade for its work in helping enhance the delivery of clinical trials through decentralisation technology.  The Queen’s Awards   Established in 1965, The Queen’s Awards for Enterprise are the… Read More

#News

#Decentralised clinical trials #Kayentis

Fully integrated platform launches for DCTs

 A fully integrated patient-centric platform has been launched to help optimise the management of hybrid and decentralised clinical trials (DCT).    The platform   The platform, developed by Kayentis, has been designed to help clinical trials providers overcome the logistical hurdles faced when bringing trials… Read More

#News

#AI / data analytics / healthtech / informatics #Biotechnology #Clinical trials #Comment #Data science #Decentralised clinical trials #Digital

Predictions and perspectives on the future of DCTs 

"The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions", says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex than ever, and sites and… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis